News Daily News Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure Michael O'Riordan December 30, 2025
News Daily News Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel L.A. McKeown August 23, 2023
News Daily News ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel L.A. McKeown August 22, 2023
News Daily News Reduction in BP Drives Treatment Preference for Hypertensive Patients Michael O'Riordan December 20, 2022
News Conference News AHA 2022 SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint Todd Neale November 09, 2022
News Conference News TCT 2022 RADIANCE II Confirms Ultrasound-Based Renal Denervation Lowers BP Todd Neale September 18, 2022
News Daily News Renal Denervation a Third Option for Hypertension, European Experts Say Todd Neale September 17, 2021
News Daily News Smartphone Selfie May Reveal BP Levels, Early Results Suggest Todd Neale August 07, 2019
News Conference News SCCT 2019 Imaging, Genes, Wearables: Some Predictions for the Future of Preventive Cardiology Yael L. Maxwell July 15, 2019
News Conference News EuroPCR 2019 Small Study Lends Further Support to the Antiarrhythmic Potential of Renal Denervation L.A. McKeown June 06, 2019
News Daily News Newly Defined Stage 1 Hypertension Tied to CVD Risk in Younger Chinese Adults Todd Neale September 07, 2018
News Industry News Medicure Announces FDA Approval of Acute Care Cardiovascular Drug Sodium Nitroprusside Injection August 14, 2018
News Daily News PREDICT-1° CVD Risk Calculator, Based on Present-Day Patients, Beats ACC/AHA ‘Pooled Cohort’ Equations Michael O'Riordan May 10, 2018
News Conference News ISC 2017 Big Fluctuations in Blood Pressure Signal a Higher Stroke Risk in Well-Controlled Hypertensives Todd Neale February 24, 2017
News Features Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter Michael O'Riordan January 10, 2017